May 9 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 5.06 4.92 5.40 2.65
(+2.7 pct) (+6.7 pct) (+6.8 pct) (+6.5 pct)
Operating 865 mln 821 mln 800 mln 400 mln
(+5.4 pct) (+9.8 pct) (-7.5 pct) (-22.7 pct)
Recurring 928 mln 853 mln 800 mln 400 mln
(+8.7 pct) (+9.8 pct) (-13.8 pct) (-23.8 pct)
Net 637 mln 568 mln 550 mln 275 mln
(+12.3 pct) (+10.9 pct) (-13.8 pct) (-25.7 pct)
EPS 152.26 yen 136.13 yen 131.26 yen 65.63 yen
Ann Div 32.00 yen 25.00 yen 32.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 32.00 yen 25.00 yen 32.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T